APLSApellis Pharmaceuticals Inc
APLS
Apellis Pharmaceuticals Inc3,622
Mkt Cap
$5.25BVolume
68.61M52W High
$41.1452W Low
$16.61PE Ratio
41.01APLS Fundamentals
Price
$41.03Prev Close
$41.06Open
$41.0550D MA
$35.35Beta
1.25Avg. Volume
5.78MEPS (Annual)
$0.1724P/B
12.65Rev/Employee
$1.36M$3,268.56
Bright Horizons Family Solutions and Remitly Global Set to Join S&P SmallCap 600
Bright Horizons Family Solutions and Remitly Global Set to Join S&P SmallCap 600 Bright Horizons Family Solutions and Remitly Global Set to Join S&P SmallCap 600 PR Newswire NEW YORK, May 7, 2026 NEW...
Compared to Estimates, Apellis Pharmaceuticals (APLS) Q1 Earnings: A Look at Key Metrics
The headline numbers for Apellis Pharmaceuticals (APLS) give insight into how the company performed in the quarter ended March 2026, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Apellis Pharmaceuticals, Inc. (APLS) Tops Q1 Earnings and Revenue Estimates
Apellis Pharmaceuticals (APLS) delivered earnings and revenue surprises of +139.30% and +33.65%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?
Apellis Pharmaceuticals (NASDAQ:APLS) Reaches New 52-Week High - Here's What Happened
Apellis Pharmaceuticals (NASDAQ:APLS) Sets New 12-Month High - What's Next...
Apellis Pharmaceuticals, Inc. (NASDAQ:APLS) Receives Consensus Recommendation of "Hold" from Analysts
Shares of Apellis Pharmaceuticals, Inc. (NASDAQ:APLS - Get Free Report) have been assigned an average recommendation of "Hold" from the twenty-three ratings firms that are presently covering the company, MarketBeat Ratings reports. Two analysts have rated the stock with a sell rating, eighteen have...
Top 3 Health Care Stocks That May Collapse This Month
Stocks AVNS, APLS, and CERS in healthcare sector flashing warning to momentum-sensitive investors. High RSI values & price action indicate overbought conditions. AVNS at 90. APLS at 86. CERS at 86...
Pictet Asset Management Holding SA Has $9.84 Million Stock Holdings in Apellis Pharmaceuticals, Inc. $APLS
Pictet Asset Management Holding SA grew its holdings in Apellis Pharmaceuticals, Inc. (NASDAQ:APLS - Free Report) by 7.5% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 390,884 shares of the company's stock after acquiring an...
UBS Group AG Boosts Stake in Apellis Pharmaceuticals, Inc. $APLS
UBS Group AG raised its holdings in Apellis Pharmaceuticals, Inc. (NASDAQ:APLS - Free Report) by 22.1% during the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 4,186,222 shares of the company's stock after purchasing an additio...
Jennison Associates LLC Reduces Holdings in Apellis Pharmaceuticals, Inc. $APLS
Jennison Associates LLC cut its stake in shares of Apellis Pharmaceuticals, Inc. (NASDAQ:APLS - Free Report) by 65.4% in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 1,504,299 shares of the company's stock after selling 2,843...
ANI Pharmaceuticals (ANIP) Expected to Beat Earnings Estimates: Should You Buy?
ANI (ANIP) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
<
1
2
...
>
Compact View
Not available
Not available